Document Detail

Longitudinal determination of serum placental protein 13 during development of preeclampsia.
MedLine Citation:
PMID:  18753763     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To determine maternal serum placental protein 13 (PP13) in normal pregnancy and preeclampsia. METHODS: A prospective, longitudinal study with 41 normal pregnant women, 18 cases with preterm delivery or cervix insufficiency and 4 with developing late-onset preeclampsia. Six hundred and sixty-six maternal blood samples were obtained every 2-4 weeks starting at 5-8 weeks gestation (10-12 samples/patient) and tested for serum PP13 by ELISA. RESULTS: In normal pregnant women delivering at term, median maternal serum PP13 levels were growing from 166 to 202 pg/ml and 382 pg/ml in the first, second and third trimester, respectively. Preeclamptic women had significantly reduced PP13 levels in the first trimester (multiples of median of 0.14 at 7-8 weeks; p = 0.005 compared to normal). PP13 in the third trimester was significantly higher compared to normal at 35-36 weeks with PP13 multiples of median of 1.79. CONCLUSION: This preliminary study indicates that low levels of PP13 in early pregnancy identify at-risk pregnancies, whereas high levels precede the syndrome in late pregnancy and suggest syncytiotrophoblast necrosis.
Berthold Huppertz; Marei Sammar; Ilana Chefetz; Peruka Neumaier-Wagner; Clemens Bartz; Hamutal Meiri
Related Documents :
429513 - Acid-ethanol-extractable nonsuppressible insulin-like activity (nsila-s) during pregnan...
2011913 - Serum melatonin during human pregnancy.
9061563 - Social factors and the meaning of food in adherence to medical diets: results of a mate...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-08-28
Journal Detail:
Title:  Fetal diagnosis and therapy     Volume:  24     ISSN:  1421-9964     ISO Abbreviation:  Fetal. Diagn. Ther.     Publication Date:  2008  
Date Detail:
Created Date:  2008-10-21     Completed Date:  2009-01-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9107463     Medline TA:  Fetal Diagn Ther     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  230-6     Citation Subset:  IM    
Copyright Information:
Copyright 2008 S. Karger AG, Basel.
Institute of Cell Biology, Histology and Embryology, Centre of Molecular Medicine, Medical University of Graz, Graz, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / blood
Galectins / blood*
Longitudinal Studies
Middle Aged
Placenta / metabolism
Pre-Eclampsia / blood
Pregnancy Proteins / blood*
Pregnancy Trimester, First / blood
Pregnancy Trimester, Second / blood
Pregnancy Trimester, Third / blood
Prospective Studies
Reg. No./Substance:
0/Biological Markers; 0/Galectins; 0/LGALS13 protein, human; 0/Pregnancy Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Survival in primary congenital pulmonary lymphangiectasia with hydrops fetalis.
Next Document:  Percutaneous fetal sclerotherapy for congenital cystic adenomatoid malformation of the lung.